BSE (bovine spongiform encephalopathy) panic reactions in Europe shake device manufacturers
This article was originally published in Clinica
Executive Summary
There is an increasing sense of urgency among the European authorities for action to safeguard patients against the potential risk of transferring bovine spongiform encephalopathy (BSE) through the use of medical devices. Some member states have lost patience waiting for the publication of the Commission's decision on European requirements for medical devices containing animal-derived products, which has been pending for some time (see Clinica No 948, p 4), and taken unilateral action.